Jian-Cheng Ni

Jian-Cheng Ni

Auto-generated profile, based on publicly available information

Jian-Cheng Ni

Network Information Center, Qufu Normal University, Qufu, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Bioinformatics
Verified
Journal Article
Open access
PDF file
CJCunmei Ji
Cunmei Ji
ZGZhen Gao
Zhen Gao
XMXu Ma
Xu Ma
QWQingwen Wu
Qingwen Wu
JNJiancheng Ni
Jiancheng Ni
CZChunhou Zheng
Chunhou Zheng
MicroRNAs (miRNAs) are a class of non-coding RNAs that play critical roles in various biological processes. Many studies have shown that miRNAs are closely related to the occurrence, development and diagnosis of human diseases. Traditional biological experiments are costly and time consuming. As a result, effective computational models have become increasingly popular for predicting associations between miRNAs and diseases, which could effectively boost human disease diagnosis and prevention. We propose a novel computational framework, called AEMDA, to identify associations between miRNAs and diseases. AEMDA applies a learning-based method to extract dense and high-dimensional representations of diseases and miRNAs from integrated disease semantic similarity, miRNA functional similarity and heterogeneous related interaction data. In addition, AEMDA adopts a deep autoencoder that does not need negative samples to retrieve the underlying associations between miRNAs and diseases. Furthermore, the reconstruction error is used as a measurement to predict disease-associated miRNAs. Our experimental results indicate that AEMDA can effectively predict disease-related miRNAs and outperforms state-of-the-art methods. The source code and data are available at https://github.com/CunmeiJi/AEMDA. Supplementary data are available at Bioinformatics online.

12 July 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
LLLei Li
Lei Li
GZGao Zhen
Gao Zhen
YWYu-Tian Wang
Yu-Tian Wang
MZMing-Wen Zhang
Ming-Wen Zhang
JNJian-Cheng Ni
Jian-Cheng Ni
YSYansen Su
Yansen Su
MiRNAs belong to small non-coding RNAs that are related to a number of complicated biological processes. Considerable studies have suggested that miRNAs are closely associated with many human diseases. In this study, we proposed a computational model based on Similarity Constrained Matrix Factorization for miRNA-Disease Association Prediction (SCMFMDA). In order to effectively combine different disease and miRNA similarity data, we applied similarity network fusion algorithm to obtain integrated disease similarity (composed of disease functional similarity, disease semantic similarity and disease Gaussian interaction profile kernel similarity) and integrated miRNA similarity (composed of miRNA functional similarity, miRNA sequence similarity and miRNA Gaussian interaction profile kernel similarity). In addition, the L2 regularization terms and similarity constraint terms were added to traditional Nonnegative Matrix Factorization algorithm to predict disease-related miRNAs. SCMFMDA achieved AUCs of 0.9675 and 0.9447 based on global Leave-one-out cross validation and five-fold cross validation, respectively. Furthermore, the case studies on two common human diseases were also implemented to demonstrate the prediction accuracy of SCMFMDA. The out of top 50 predicted miRNAs confirmed by experimental reports that indicated SCMFMDA was effective for prediction of relationship between miRNAs and diseases.

18 March 2021 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
CJCunmei Ji
Cunmei Ji
YWYutian Wang
Yutian Wang
GZGao Zhen
Gao Zhen
LLLei Li
Lei Li
JNJiancheng Ni
Jiancheng Ni
CZChunhou Zheng
Chunhou Zheng
MicroRNAs (miRNAs) are a class of non-coding RNAs that play critical role in many biological processes, such as cell growth, development, differentiation and aging. Increasing studies have revealed that miRNAs are closely involved in many human diseases. Therefore, the prediction of miRNA-disease associations is of great significance to the study of the pathogenesis, diagnosis and intervention of human disease. However, biological experimentally methods are usually expensive in time and money, while computational methods can provide an efficient way to infer the underlying disease-related miRNAs. In this study, we propose a novel method to predict potential miRNA-disease associations, called SVAEMDA. Our method mainly consider the miRNA-disease association prediction as semi-supervised learning problem. SVAEMDA integrates disease semantic similarity, miRNA functional similarity and respective Gaussian interaction profile (GIP) similarities. The integrated similarities are used to learn the representations of diseases and miRNAs. SVAEMDA trains a variational autoencoder based predictor by using known miRNA-disease associations, with the form of concatenated dense vectors. Reconstruction probability of the predictor is used to measure the correlation of the miRNA-disease pairs. Experimental results show that SVAEMDA outperforms other stat-of-the-art methods. AUC values of SVAEMDA of global leave-one-out cross validation (LOOCV) and 5-fold cross validation (5-fold CV) are 0.9464 and 0.9428 respectively. In addition, case studies of three common human diseases indicate that SVAEMDA obtains 100 percent of the top 50 predicted candidates in the benchmark databases. Therefore, SVAEMDA can efficiently and accurately predict the potential associations between diseases and miRNAs.

26 September 2023 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
STSheng-Wen Tian
Sheng-Wen Tian
JNJian-Cheng Ni
Jian-Cheng Ni
YWYu-Tian Wang
Yu-Tian Wang
CZChunhou Zheng
Chunhou Zheng
CJCunmei Ji
Cunmei Ji
Single-cell RNA sequencing (scRNA-seq) has rapidly emerged as a powerful technique for analyzing cellular heterogeneity at the individual cell level. In the analysis of scRNA-seq data, cell clustering is a critical step in downstream analysis, as it enables the identification of cell types and the discovery of novel cell subtypes. However, the characteristics of scRNA-seq data, such as high dimensionality and sparsity, dropout events and batch effects, present significant computational challenges for clustering analysis. In this study, we propose scGCC, a novel graph self-supervised contrastive learning model, to address the challenges faced in scRNA-seq data analysis. scGCC comprises two main components: a representation learning module and a clustering module. The scRNA-seq data is first fed into a representation learning module for training, which is then used for data classification through a clustering module. scGCC can learn low-dimensional denoised embeddings, which is advantageous for our clustering task. We introduce Graph Attention Networks (GAT) for cell representation learning, which enables better feature extraction and improved clustering accuracy. Additionally, we propose five data augmentation methods to improve clustering performance by increasing data diversity and reducing overfitting. These methods enhance the robustness of clustering results. Our experimental study on 14 real-world datasets has demonstrated that our model achieves extraordinary accuracy and robustness. We also perform downstream tasks, including batch effect removal, trajectory inference, and marker genes analysis, to verify the biological effectiveness of our model. The code of scGCC is freely available at https://github.com/tswstart/scGCC .

16 September 2021 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
QWQing-Wen Wu
Qing-Wen Wu
RCRuifen Cao
Ruifen Cao
JXJunfeng Xia
Junfeng Xia
JNJian-Cheng Ni
Jian-Cheng Ni
CZChunhou Zheng
Chunhou Zheng
YSYansen Su
Yansen Su
Lots of experimental studies have revealed the significant associations between lncRNAs and diseases. Identifying accurate associations will provide a new perspective for disease therapy. Calculation-based methods have been developed to solve these problems, but these methods have some limitations. In this paper, we proposed an accurate method, named MLGCNET, to discover potential lncRNA-disease associations. Firstly, we reconstructed similarity networks for both lncRNAs and diseases using top k similar information, and constructed a lncRNA-disease heterogeneous network (LDN). Then, we applied Multi-Layer Graph Convolutional Network on LDN to obtain latent feature representations of nodes. Finally, the Extra Trees was used to calculate the probability of association between disease and lncRNA. The results of extensive 5-fold cross-validation experiments show that MLGCNET has superior prediction performance compared to the state-of-the-art methods. Case studies confirm the performance of our model on specific diseases. All the experiment results prove the effectiveness and practicality of MLGCNET in predicting potential lncRNA-disease associations.

18 February 2020 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
GZGao Zhen
Gao Zhen
YWYu-Tian Wang
Yu-Tian Wang
QWQing-Wen Wu
Qing-Wen Wu
JNJian-Cheng Ni
Jian-Cheng Ni
CZChunhou Zheng
Chunhou Zheng
Background: The aberrant expression of microRNAs is closely connected to the occurrence and development of a great deal of human diseases. To study human diseases, numerous effective computational models that are valuable and meaningful have been presented by researchers.Results: Here, we present a computational framework based on graph Laplacian regularizedL2,1-nonnegative matrix factorization (GRL2,1-NMF) for inferring possible human disease-connected miRNAs. First, manually validated disease-connected microRNAs were integrated, and microRNA functional similarity information along with two kinds of disease semantic similarities were calculated. Next, we measured Gaussian interaction profile (GIP) kernel similarities for both diseases and microRNAs. Then, we adopted a preprocessing step, namely, weighted K nearest known neighbours (WKNKN), to decrease the sparsity of the miRNA-disease association matrix network. Finally, theGRL2,1-NMF framework was used to predict links between microRNAs and diseases.Conclusions: The new method (GRL2, 1-NMF) achieved AUC values of 0.9280 and 0.9276 in global leave-one-out cross validation (global LOOCV) and five-fold cross validation (5-CV), respectively, showing that GRL2, 1-NMF can powerfully discover potential disease-related miRNAs, even if there is no known associated disease.